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Abstract
Insulin-producing pancreatic islet b cells (b-cells) are destroyed, severely depleted or functionally impaired in diabetes.
Therefore, replacing functional b-cell mass would advance clinical diabetes management. We have previously demonstrated
the importance of Cdk4 in regulating b-cell mass. Cdk4-deficient mice display b-cell hypoplasia and develop diabetes,
whereas b-cell hyperplasia is observed in mice expressing an active Cdk4R24C kinase. While b-cell replication appears to be
the primary mechanism responsible for b-cell mass increase, considerable evidence also supports a contribution from the
pancreatic ductal epithelium in generation of new b-cells. Further, while it is believed that majority of b-cells are in a state of
‘dormancy’, it is unclear if and to what extent the quiescent cells can be coaxed to participate in the b-cell regenerative
response. Here, we address these queries using a model of partial pancreatectomy (PX) in Cdk4 mutant mice. To investigate
the kinetics of the regeneration process precisely, we performed DNA analog-based lineage-tracing studies followed by
mathematical modeling. Within a week after PX, we observed considerable proliferation of islet b-cells and ductal epithelial
cells. Interestingly, the mathematical model showed that recruitment of quiescent cells into the active cell cycle promotes b-
cell mass reconstitution in the Cdk4R24C pancreas. Moreover, within 24–48 hours post-PX, ductal epithelial cells expressing
the transcription factor Pdx-1 dramatically increased. We also detected insulin-positive cells in the ductal epithelium along
with a significant increase of islet-like cell clusters in the Cdk4R24C pancreas. We conclude that Cdk4 not only promotes b-
cell replication, but also facilitates the activation of b-cell progenitors in the ductal epithelium. In addition, we show that
Cdk4 controls b-cell mass by recruiting quiescent cells to enter the cell cycle. Comparing the contribution of cell
proliferation and islet-like clusters to the total increase in insulin-positive cells suggests a hitherto uncharacterized large
non-proliferative contribution.
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Introduction
Pancreatic b-cells are uniquely endowed with the ability to
synthesize and secrete insulin – a hormone essential for glucose
control [1]. Autoimmune destruction of b-cells results in Type 1
diabetes. Type 2 diabetes is characterized by significantly reduced
b-cell mass that combines with b-cell dysfunction resulting in a
deficit in b-cell compensation mechanisms in the face of glucose
intolerance and insulin resistance [2,3,4]. Therefore, restoration of
b-cell mass is of major clinical significance in both forms of
diabetes. It is known that adult b-cells exhibit limited proliferation
capacity that is dependent on genetic background [5,6,7].
Furthermore, b-cells turn over slowly and their proliferation
potential decreases with age [8,9]. Several potential mechanisms
for regulating b-cell mass have been supported by ongoing
research [10]. Pancreatic stem cells, embryonic or arising from
diverse locations such as pancreatic ducts, islets and bone marrow,
have been proposed as sources of insulin-producing b-cells
[11,12,13,14,15,16]. Other reported sources are trans-differentia-
tion of pancreatic acinar cells, liver cells, differentiation of intra-
islet precursors or splenocytes, and epithelial-mesenchymal
transition [17,18,19,20,21,22,23], although recent studies have
challenged some of these findings [24,25,26]. Furthermore,
induced genetic reprogramming of adult exocrine cells to
functional b-cells has been recently reported [27]. Among these
possible sources, elegant lineage tracing analyses and other
approaches convincingly demonstrate that b-cell self-duplication
is a dominant source of adult b-cells [28,29,30]. A recent report
shows the existence of facultative stem cells in the pancreatic
ductal epithelium and their recruitment in response to an acute
pancreatic injury [31]. These results suggest that the two major
mechanisms that increase b-cell mass are (i) duplication of pre-
existing b-cells and (ii) generation of b-cells via recruitment of
facultative stem/progenitor cells within the pancreatic ductal
epithelium.
The cell cycle machinery receives signals transduced by various
growth factor pathways and controls cellular quiescence, prolifer-
ation, differentiation, senescence, and apoptosis [32,33]. The
retinoblastoma protein (RB) negatively regulates the passage of
cells from G1 to S phase primarily by sequestering E2F
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transition. Cyclin-dependent kinases (Cdk’s) promote S-phase
progression and mitosis by phosphorylating and, thereby,
inactivating RB. The activity of Cdk’s is negatively regulated by
the Ink4 and Cip/Kip families of cyclin-dependent kinase
inhibitors (Cki’s). Using mice with genetically modified Cdk4 loci,
we have previously shown that Cdk4 regulates b-cell mass
[33,34,35,36]. Cdk4
2/2 mice exhibit b-cell hypoplasia and
develop diabetes, whereas Cdk4
R24C/R24C mice (Cdk4
R/R mice),
inheriting the p16
Ink4a-insensitive Cdk4
R24C kinase, exhibit b-cell
hyperplasia. Several recent studies have underscored the impor-
tant roles of other cell cycle regulators in b-cell biology
[37,38,39,40,41,42,43].
While it is known that Cdk4 influences the size of the post-natal
b-cell compartment, it is unknown whether this kinase regulates b-
cell mass in response to regenerative stimuli and physiological
demand. Cdk4
R24C promotes autoreactivity in the immune system
when backcrossed onto the non-obese diabetic (NOD) background
but it also protects pancreatic b-cell mass from autoimmune
destruction when introduced into the NOD/SCID mouse [44].
While b-cell replication appears to be the primary mechanism
responsible for b-cell mass increase [28,29,30], considerable
evidence also supports a contribution from the pancreatic ductal
epithelium in generation of new b-cells [12,31,45,46,47,48].
However, the molecular regulators that govern the processes of b-
cell replication or progenitor cell activation are not known and it is
unclear whether Cdk4 regulates b-cell mass via either of these
mechanisms. Further, while it is believed that the majority of b-cells
are in a state of ‘dormancy’, it is not clear if and to what extent these
quiescentcellscanbecoaxedtoparticipateintheb-cellregenerative
response. We address these issues in the present study. Our results
demonstrate that Cdk4 enhances b-cell replication within islets and
activates progenitors within the pancreatic ductal epithelium in
response to partial pancreatectomy. Further, mathematical model-
ing of data derived upon DNA analog-based lineage-tracing
suggests that Cdk4 recruits quiescent islet b-cells and ductal b-cell
progenitors into a proliferation cycle. These results underscore the
critical role played by Cdk4 in the regulation of b-cell mass.
Results
Efficient b-Cell Regeneration in Cdk4
R/R Mice in Response
to Pancreatectomy
Considering the critical role of Cdk4 in regulating post-natal b-
cell mass [33,36], we set out to determine its importance in
controlling b-cell replication within islets and in modulating the
activity of presumptive progenitor cells in the pancreatic ductal
epithelium. The processes of islet b-cell replication and ductal
progenitor cell activation can be simultaneously analyzed in a 60%
partial pancreatectomy (PX) model [49]. We performed 60% PX
in 8-week-old Cdk4-wild type (Cdk4
WT) and Cdk4
R/R mice. Sham-
operated mice from both genotypes served as controls. Mice were
observed for a period of 28 days post-PX. No significant changes
in body weights were observed in either the Cdk4
WT or Cdk4
R/R
mice post-PX (Fig. 1A), and, consistent with prior reports [49,50],
no significant hyperglycemia was observed in either genotype
(Fig. 1B), thus excluding hyperglycemia as a major factor
underlying the regenerative response. Comparable b-cell mass
was observed in Cdk4
WT and Cdk4
R/R mice immediately after PX
(day 0), whereas, 14 days after PX, a significant increase in b-cell
mass was observed in the Cdk4
R/R mice, compared with Cdk4
WT
mice (Fig. 1C). The b-cell mass increase observed in Cdk4
WT mice
is consistent with that reported by Peshavaria et al., using a similar
60% PX model [49]. No further increase in b-cell mass was seen at
day 28 post-PX in mice of either genotype. These observations
indicate that Cdk4
R24C promotes rapid b-cell regeneration in
response to PX.
Increased Islet b-Cell Replication in Cdk4
R/R Mice
following Pancreatectomy
We quantified b-cell proliferation in the Cdk4
WT and Cdk4
R/R
mice post-PX by staining for both bromodeoxyuridine (BrdU) and
Figure 1. Enhanced regeneration of b-cell mass in Cdk4
R/R mice
in response to partial pancreatectomy (PX). (A) Body weight
change and (B) fed-state blood glucose levels were measured before
(day 0) and on indicated days after PX on Cdk4
WT mice (open squares)
and Cdk4
R/R mice (closed squares). (C) b-cell mass is increased after PX
in both groups. Significant increase of b-cell mass was observed in
Cdk4
R/R mice (closed bars) compared with Cdk4
WT mice (open bars) by
14 days after PX. Data are shown as means and error bars represent S.E.
*p,0.05 vs Cdk4
WT mice.
doi:10.1371/journal.pone.0008653.g001
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significant difference in b-cell proliferation, as measured by counting
BrdU
+:Ins
+ cells, was observed in Cdk4
WT and Cdk4
R/R pancreas
immediately after PX (day 0) or 1 day after PX (Fig. 2A). A more
than two-fold increase in b-cell proliferation was seen in Cdk4
WT and
Cdk4
R/R mice by day 2 post-PX. No further increase in b-cell
replication was seen in the Cdk4
WT islets after day 2 post-PX. In
contrast, a significant increase in b-cell proliferation was seen at day
14 post-PX in the Cdk4
R/R islets. These observations demonstrate
enhanced islet b-cell proliferation post-PX in Cdk4
R/R mice.
Enhanced Pancreatic Ductal Epithelial Cell Proliferation in
Cdk4
R/R Mice
The pancreatic ductal epithelium has been proposed to serve as a
reservoir of potential facultative progenitor cells capable of
differentiating into b-cells [45]. Indeed, the recruitment of such
progenitors is observed in response to pancreatic injury [31]. We
looked for evidence suggestive of ductal progenitor cell activation in
Cdk4
WT and Cdk4
R/R mouse pancreas post-PX. First, we estimated
pancreatic ductal epithelial cell proliferation by BrdU staining
combined with staining for cytokeratin (CK) as a ductal epithelium
marker. We observed very low levels of ductal cell proliferation in
Cdk4
WT pancreas prior to and at any time after PX (Fig. 2B). On the
other hand, ductal cell proliferation was significantly increased in
Cdk4
R/R pancreas before PX (day 0) and at day 1 post-PX (Fig. 2B).
Interestingly,ductalcellproliferationincreasedmore than10-foldin
the Cdk4
R/R pancreas by day2 post-PX. The significant elevation of
ductal epithelial cell proliferation was maintained in the Cdk4
R/R
pancreas until day 14 post-PX, although the absolute cell
proliferation was less than that seen at day 2 post-PX. These data
demonstrate robustductalcell proliferationinthe Cdk4
R/Rpancreas
as early as 2 days after PX.
Kinetics of Proliferation in Islet b-Cells and Ductal
Epithelial Cells after Pancreatectomy
To observe cell-division kinetics in detail, we adapted a DNA
analog-based lineage-tracing technique using dual thymidine
analogs, 5-chloro-2-deoxyuridine (CldU) and 5-iodo-2-deoxyuri-
dine (IdU) [30]. Each thymidine analog detects a distinct round of
cell division;thus, itallowsestimation ofmore than one round ofcell
division in vivo when the two analogs are sequentially provided in
drinking water over defined time-periods. As schematically depicted
in Fig. 3A, mice were provided CldU-containing water during the
first pulse period, IdU-containing water during the second pulse
period, and water without any DNA analogs during a chase period.
We used three protocols each with different administration periods
(Fig. 3B). The first protocol, 2-2-4 (first pulse period-second pulse
period-measure time point), was designed to identify cell division
Figure 2. Increased islet b-cell and ductal epithelial cell proliferation after PX in Cdk4
R/R mice. (A) Islet b-cell proliferation was significantly
increased in Cdk4
R/R mice (closed bars) compared with Cdk4
WT mice (open bars) by 14 days after PX. The picture on the left shows BrdU
+ (brown) and
insulin
+ (blue) b-cell (red arrow) and BrdU negative b-cell (yellow arrow). (B) Proliferation of pancreatic ductal epithelial cells was significantly
increased within 2 days post-PX in Cdk4
R/R mice (closed bars) compared with Cdk4
WT mice (open bars). Arrow heads in picture on left indicate BrdU
+
ductal cells. Data are shown as means and error bars represent S.E. *p,0.05, **p,0.01, and ***p,0.001 vs Cdk4
WT mice. Note that BrdU-labeled cells
result from a 16-hr-labeling period.
doi:10.1371/journal.pone.0008653.g002
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experiment, we had observed limited b-cell replication (Fig. 2A) but
significantly enhanced ductal cell proliferation (Fig. 2B). The second
protocol, 2-2-14, incorporated a 10-day chase period subsequent to
the 4-day pulse period to monitor the re-division of cells that
proliferated in the prior pulse period. The third protocol, 7-7-14,
was designed to identify cells undergoing slow division over the
entire 14 days post-PX. Immunohistochemistry with insulin and
CK identified b-cells and ductal epithelium cells, respectively, and
showed CldU
+ or IdU
+ single positive, or CldU
+:IdU
+ double
positive cells after the labeling experiment (Figs. S1 and S2). We
have summarized the labeling ratios for the three protocols in Table
S1. The ratios represent accumulated cell proliferation during each
labeling period.
Mechanism of Enhanced Cell Proliferation in Cdk4
R/R Mice
The double-labeling experiment allows us to examine the
dynamics of cell proliferation. A given labeling ratio of cell
proliferation may arise from two distinct scenarios: either all cells
proliferate at a certain rate or subsets of cells proliferate at a higher
rate. If double-labeled cells are frequently observed, the second
scenario is more probable. In this study, however, we observed rare
double-labeled (CldU
+:IdU
+) cells within a short labeling period (14
days) regardless of genotype (Table S1). A low rate of cell division can
lead to the observation of these rare double-labeled cells. However, if
cells that have proliferated once require a refractory period before
they undergo additional rounds of proliferation [30], despite the
existence of limited highly-proliferating cells, the numbers of double-
labeled cells may still remain low. We addressed these possibilities by
introducing a mathematical model that allows study of the
aforementioned events in quantitative detail to elucidate the relative
likelihoods of these distinct scenari o s( s e et h eM a t e r i a l sa n dM e t h o d s
section). In the model, we considered two cell populations of active
and quiescent cells; only active cells can proliferate. In addition, we
neglected multiple proliferation events of the active cells because such
events are sufficiently rare. Then, we fitted the data to the models
with different initial number ratios of quiescent to activecells, nQ
 
nA.
For example, nQ
 
nA~0 means there are no quiescent cells, i.e.,
every cell exhibits an equal proliferation potential. Using the cell
proliferation information from the BrdU and CldU/IdU labeling
experiments, the model predicted number changes of quiescent,
active, and proliferated cellsinisletsandducts of Cdk4
WT and Cdk4
R/R
mice (Fig. 4); the comparison between model prediction and
experimental data was shown in Table 1. Furthermore, Figure 4
showed the proliferation rate of active cells and the proportion of
proliferated cells per day. Two possibilities for enhanced cell
proliferation in Cdk4
R/R mice are accelerated proliferation of active
cells and recruitment of quiescent cells into active cell population.
Our results demonstrated no difference in cell proliferation rate of
active cell populations; average proliferation rates of active cells
during 14 days after pancreatectomy are 16.1612.3 vs. 16.4612.2
(% per day) for b-cells in Cdk4
WT and Cdk4
R/R mice; and 15.3610.8
vs. 7.560.4 (% per day) for ductal cells in Cdk4
WT and Cdk4
R/R mice.
On the other hand, the ratio of quiescent to active cell populations
decreased in both b-cells and ductal cells in Cdk4
R/R mice: 48627 vs.
18620 for b-cells in Cdk4
WT and Cdk4
R/R mice; and 56626 vs. 060
(0.0460.04) for ductal cells in Cdk4
WT and Cdk4
R/R mice.
Furthermore, model comparison, using the Bayesian model proba-
bility for the given data, pM jD ðÞ , showed that a smaller quiescent cell
population (small nQ
 
nA) is a more likely explanation of the labeling
data of Cdk4
R/R mice, compared with the labeling data of Cdk4
WT
mice (Fig. S3).
Increased Pdx-1
+ Cells in the Cdk4
R/R Pancreatic Ductal
Epithelium after Pancreatectomy
The pancreatic duodenal homeobox 1 (Pdx-1/Idx-1/Ipf-1/Stf-
1) transcription factor is an essential regulator of early pancreatic
development [51,52]. Pdx-1 is expressed in the mouse primitive
gut as early as the 13 somite stage (E8.5), about a day before
endocrine gene expression and 1.5 days before the first
morphologic evidence of pancreas organogenesis. Subsequently,
Pdx-1 is transiently present in the fetal duodenum and in
pancreatic exocrine, endocrine and ductal cells, although Pdx-1
expression is suppressed in late fetal development (E15.5). In adult
pancreas, Pdx-1 is localized mainly within b-cells where it
functions as a transcriptional regulator of b-cell specific genes
including insulin, glucokinase and glut2. Interestingly, factors that
determine organogenesis, such as Pdx-1, frequently get activated
during the regeneration processes and recapitulate stages traversed
during embryonic development. Indeed, presence of Pdx-1-
positive (Pdx-1
+) cells in the pancreatic ductal epithelium has
been demonstrated in rodent models following PX [12,47,49].
Therefore, we performed immunofluorescence assays to detect
Pdx-1 expression in the pancreatic sections from Cdk4
WT and
Cdk4
R/R mice before and after PX. The presence of ductal cells
was verified by expression of CK and the number of Pdx-1 and
CK double positive cells within the pancreatic ductal epithelium
was determined (Fig. 5A). Prior to PX, Pdx-1
+ cells were rare or
Figure 3. Schematic diagram and protocols of the double-
labeling experiment. (A) Schematic description of cell proliferation
under the double-labeling experiment. Two initial populations of nQ
quiescent (black) and nA active (white) cells are subjected to two pulse
(CldU and IdU) and one chase periods. The numbers of once- and twice-
proliferated cells are represented by nC
1 and nC
2 (during the CldU
period); nI
1 and nI
2 (during the IdU period); and n1 and n2 (during the
chase period). The number of purple twice-proliferated (once in CldU
and once in IdU) cells are denoted with nCI
2 . Note that some labeled
cells divide during the chase period and decrease their labeling
intensity. They are described with slashed green and red cells in the
chase period. (B) Three protocols of the double-labeling experiment
with two pulse periods and following chase period.
doi:10.1371/journal.pone.0008653.g003
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WT pancreatic ductal epithelium
(Fig. 5B). In contrast, higher numbers of ductal Pdx-1
+:CK
+ cells
were observed in the Cdk4
R/R pancreas before PX. The
percentage of Pdx-1
+:CK
+ ductal cells increased at day 1 post-
PX in the Cdk4
WT pancreas and reached ,3% at day 14 post-PX
(Fig. 5B). This illustrates the capacity of normal pancreas to
Figure 4. Proliferation of b-cells and ductal epithelial cells of Cdk4
WT and Cdk4
R/R mice after pancreatectomy. Changes of quiescent,
active, and proliferated cell numbers (nQ, nA, and nP) normalized by initial active cell number; proliferation rate of active cells; and ratio of proliferated
cells among entire cell population are plotted.
doi:10.1371/journal.pone.0008653.g004
Table 1. Measured and model-predicted labeling ratios.
Cdk4
WT b-cells Cdk4
R/R b-cells Cdk4
WT duct cells Cdk4
R/R duct cells
Protocol Labeling Measure Model Measure Model Measure Model Measure Model
Day 0 BrdU
+ 0.560.5 0.0 1.360.6 0.5 0.260.1 0.1 1.360.6 0.0
Day 1 BrdU
+ 0.560.5 0.6 1.160.4 1.3 0.460.4 0.3 2.861.0 1.0
Day 2 BrdU
+ 1.961.2 1.8 2.961.3 2.3 0.460.1 0.5 12.960.1 12.5
Day 14 BrdU
+ 1.860.8 1.4 4.661.8 2.0 1.261.2 1.3 5.660.1 2.1
2-2-4 CldU
+ 6.662.8 2.4 3.260.5 3.5 8.067.8 0.8 7.961.7 12.1
IdU
+ 14.8612.3 3.3 10.163.5 8.6 11.964.3 2.3 47.6643.0 20.6
2-2-14 CldU
+ 4.664.3 2.3 11.267.3 2.8 5.561.8 0.6 11.768.8 9.0
IdU
+ 8.968.4 3.2 23.0611.3 6.8 5.662.7 2.0 9.060.7 15.3
7-7-14 CldU
+ 8.062.8 9.2 19.8612.0 24.4 11.963.5 11.1 19.5614.8 43.6
IdU
+ 9.867.4 5.0 26.164.2 25.8 25.8618.2 16.7 7.565.1 31.7
Numbers are average percentages of labeled cells per protocol (n=2 to 4). The protocol name of CldU/IdU experiment represents CldU-drinking period – IdU-drinking
period – measuring day. To match the scale of BrdU-labeling experiment and CldU/IdU-labeling experiment, we scale the CldU/IdU-labeling results up with 3-fold that
was an optimized value (see the Materials and Methods). Raw counting numbers of labeled cells are also given in Table S1. The predicted values are the maximum
likelihood values.
doi:10.1371/journal.pone.0008653.t001
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+ cells in response to PX. Significantly,
the activation was greater in the Cdk4
R/R pancreatic ductal
epithelium, where we observed a 5-fold increase in the ratio of
Pdx-1
+:CK
+ cells within 1 day after PX, and a further significant
increase in the ratio at day 2 post-PX. However, at day 14 post-
PX, the ratio was reduced to a level comparable to the ratio
observed in the Cdk4
WT pancreas at day 14 post-PX. These
observations demonstrate a significantly-increased pool of Pdx-
1
+:CK
+ ductal epithelial cells in the regenerating Cdk4
R/R
pancreas as an immediate early response to PX.
Increased Islet-Like Cell Clusters in Cdk4
R/R Pancreas after
Pancreatectomy
To determine whether insulin is expressed in the ductal
epithelium of the Cdk4
R/R pancreas, we performed immunofluo-
rescence assays using insulin and CK antibodies to detect Ins and
CK double positive cells. Ins
+:CK
+ cells were either rare or
undetectable in the ductal epithelium of the Cdk4
WT pancreas
either before or after PX. In contrast, Ins
+:CK
+ cells were
frequently seen in the ductal epithelium of the Cdk4
R/R pancreas
post-PX (data not shown). In response to regeneration, co-incident
with the appearance of the rare Ins
+ ductal epithelial cells, small
islet-like cell clusters (ICCs) have been reported to originate in the
vicinity of the ductal epithelium [49]. Further, ICCs are
considered to represent newly-differentiated b-cells that originate
from progenitors localized within the ductal epithelium. We next
counted the number of ICCs (ie. those clusters with fewer than 5
b-cells) near the pancreatic ducts before and after PX in our
experimental mice (Fig. 6A). Prior to PX, we observed a modest
yet significant increase in the number of duct-associated ICCs in
the Cdk4
R/R pancreas (Fig. 6B). No increase in the number of
ICCs was observed in the Cdk4
WT pancreas by day 2 post-PX,
although a significant increase in the number of ICCs was seen at
day 14 post-PX. Interestingly, we detected a significant ,3-fold
increase in the number of ICCs in Cdk4
R/R pancreas as early as
day 2 post-PX (Fig. 6B). Moreover, the number of ICCs in the
Cdk4
R/R pancreas continued to rise significantly and by day 14
post-PX were increased by ,5-fold compared with the number of
ICCs prior to PX. Together, these observations demonstrate the
ability of the Cdk4
R/R pancreatic ductal epithelium to (i) proliferate
extensively, (ii) express the putative pancreatic progenitor marker,
Pdx-1, (iii) express insulin, a marker of mature differentiated b-
cells, and (iv) promote the development of insulin-positive small
ICCs.
Figure 5. Pdx-1 expression in pancreatic ductal epithelial cells
from Cdk4
R/R mice after pancreatectomy. (A) A representative
picture of Pdx-1 expression observed within the cytokeratin (CK)-
positive pancreatic ductal epithelium from Cdk4
R/R mice. Arrows show
Pdx-1
+:CK
+ cells. Blue color identifies DAPI-stained nuclei. (B) Percent-
age of Pdx-1
+ ductal epithelial cells was significantly increased by 2 days
post-PX in Cdk4
R/R mice (closed bars) compared with Cdk4
WT mice
(open bars). Data are shown as means from four mice of each genotype
per group and error bars represent S.E. **p,0.01, and ***p,0.001 vs
Cdk4
WT mice.
doi:10.1371/journal.pone.0008653.g005
Figure 6. Increased number of islet-like cell clusters (ICCs) in
pancreatectomized Cdk4
R/R mice. (A) The number of ICCs that
contain 5 or less insulin
+ cells was counted. Left picture shows DAPI
staining and the pancreatic duct (D) is identified by white stippled line.
Right picture shows the mature islet (I) and an ICC (yellow arrow)
identified upon immunofluorescence staining with insulin antibodies.
(B) Number of ICCs was significantly increased before and after PX in
Cdk4
R/R mice (closed bars) compared with Cdk4
WT mice (open bars).
Values are the results obtained from four mice per group at each time
point and expressed as mean number of ICCs per section. Error bars
represent S.E. *p,0.05, **p,0.01, and ***p,0.001 vs Cdk4
WT mice.
doi:10.1371/journal.pone.0008653.g006
b-cell regeneration mechanisms
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b-cells, like all other cells, are under the regulatory checks and
balances enforced by changes in cell cycle progression [33]. Proof
of this concept was provided using mouse models wherein the
locus that codes for Cdk4, one of the important gate-keepers of
the mammalian cell cycle machinery, was targeted by genetic
recombineering [36,53]. These studies illustrated that loss of
Cdk4 results in b-cell hypoplasia and diabetes. In contrast,
inheritance of a mutant Cdk4
R24C kinase, that is refractory to cell
cycle inhibition by p16
Ink4a, resulted in b-cell hyperplasia [35,36].
Although these studies illustrated the unique role of Cdk4 in b-
cell mass regulation, the mechanisms by which Cdk4 controls b-
cell mass have remained unclear. Here, using a model of partial
pancreatectomy, we showed that Cdk4 regulates post-natal b-cell
mass by targeting two different cellular compartments: the pre-
existing b-cells within islets and presumptive progenitors localized
in the pancreatic ductal epithelium. Furthermore, we show that
Cdk4 utilizes two distinct mechanisms to engineer b-cell mass re-
constitution in response to pancreatectomy. First, the data is
compatible with Cdk4 promotion of islet b-cell replication, a
mechanism that is presumed to play a primary role in regulating
b-cell mass. Second, Cdk4 catalyzes the recruitment of quiescent
cells within the islets and the ductal epithelium to participate in
the regenerative process. Interestingly, recruitment of quiescent
cells within the ductal epithelium displays hallmarks of early
pancreatic development [12]. Therefore, pancreatectomy induces
rapid proliferation of ductal epithelial cells and a coincident
significant increase in cells that express Pdx-1, a transcription
factor that is involved in the earliest stages of embryonic pancreas
development. The rapid proliferation kinetics combined with the
appearance of Pdx-1
+ cells suggests involvement of activated
progenitors in response to injury. Moreover, we observe
increased insulin-positive cells in the ductal epithelium and a
significant enhancement in the number of duct-associated small
ICCs. Together, we illustrate that Cdk4 stimulates b-cell
regeneration by promoting b-cell replication and inducing
progenitor cell activation by recruitment of quiescent cells into
the active cell cycle (Fig. 7).
We estimated contributions of both the mechanisms -
replication and recruitment from quiescence - to the overall
increase in b-cell mass during 14 days after pancreatectomy
(0.2560.29 to 0.8560.38 mg in Cdk4
WT pancreas; and from
0.3860.10 to 1.5560.28 mg in Cdk4
R/R pancreas). Estimated
contributions by b-cell proliferation are 8% (,0.02 mg) and 34%
(,0.13 mg) of the total increase of initial b-cell mass for Cdk4
WT
and Cdk4
R/R pancreas, respectively (Fig. 4). Next, we estimated the
ICC contributions that represent islet neogenesis from ducts.
Assuming that 500 sections can be obtained from a pancreas and
single cell mass can be estimated from water density
(,1.8610
26 mg/cell), increasing numbers of ICCs correspond
to 0.09 mg for Cdk4
WT and 0.23 mg for Cdk4
R/R pancreas. In
spite of a large variation of b-cell mass changes, contributions from
b-cell replication and ICCs (defined cell clusters including below 5
cells) are not sufficient to explain the b-cell mass increase during
14 days after pancreatectomy. Proliferation was assayed by two
methods: (i) BrdU incorporation by intra-peritoneal injection, and
(ii) by administration of CIdU and IdU via drinking water.
Kushner’s laboratory has shown that CldU/IdU labeling is as
efficient as BrdU labeling at detecting b-cell proliferation [30],
thus we believe that our results accurately reflect the numbers of
proliferating cells in the Cdk4 models. However, it is possible that
the BrDU and CIdU/IdU labeling indices may be under-
estimated in our analyses although it is unlikely that would
explain such a large gap in b-cell mass increase. Taken together,
we suggest the possibility of non-proliferative contribution to the
b-cell mass increase. For example, b-cell hypertrophy may be
partially responsible for the observed b-cell mass increase. Further,
mechanisms that involve compensatory de-differentiation could
account for increase to b-cell mass. Indeed, Collombat and
colleagues recently illustrated a mechanism of expansion of the b-
cell mass in response to injury wherein pancreatic progenitor cells
are capable of giving rise to glucagon-expressing a-cells that then
transdifferentiate into b-cells [54,55]. Importantly, it was shown
that the continuous neogenesis of b-cells through the cell re-
differentiation program did not involve b-cell self-renewal [54].
The possible existence of a large non-proliferative source of b-cells
is surprising given the knowledge of replication-competent b-cells
that drive regeneration of b-cell mass [28,29,30]. We do observe
substantial numbers of proliferating cells in response to pancre-
atectomy and indeed Cdk4
R24C seems to promote the proliferation
process. However, in addition we find a hitherto uncharacterized
large non-proliferative pool of cells that Cdk4 can coax to
participate in the regenerative response. It should be noted that
distinct populations of quiescent and proliferative b-cells have
been identified in another model organism recently [56].
Prior to the restriction point, cells can temporarily exit the cell
cycle and undergo quiescence – a distinct out-of-cycle state that is
under active genetic control (Fig. 7A). Previously, we and others
have shown that loss of Cdk4 results in delayed S-phase entry from
quiescence and a prolonged S phase [36,53]. Here, we showed
that Cdk4
R24C promoted b-cell proliferation within islets via a
process of self-duplication. In addition, the mathematical model
suggested that Cdk4
R24C may recruit quiescent cells in islets to re-
enter the cell cycle. The most dramatic effect of Cdk4
R24C appears
to be in the pancreatic ductal epithelium where we observed rapid
proliferation activity and strong activation of the early develop-
mental marker Pdx-1 within 24–48 hours after pancreatectomy.
The appearance of Pdx-1
+ cells in the regenerating ductal
epithelium of the Cdk4
R/R pancreas is suggestive of progenitor/
stem cell activation in response to pancreatectomy and lineage
tracing analyses will offer conclusive evidence in this regard. It has
been postulated that the size of the pancreas is fixed during
development due to the limited number of progenitor cells [57].
Our findings suggest that such presumptive progenitors may be
responsive to context-dependent activation, such as injury. Similar
activation of endocrine pancreatic progenitor cells, expressing the
endocrine marker neurogenin 3 (Ngn3), has been reported in
response to duct-ligation [31]. We did not observe Ngn3
+ cells in
our study before or after pancreatectomy. It is plausible that the
two types of injuries, pancreatectomy versus duct-ligation, may
foster activation of distinct progenitor cell populations that express
either Pdx1 or Ngn3. Moreover, it is likely that the 60%
pancreatectomy may be a relatively mild injury compared with
the duct-ligation technique that may elicit a distinct genetic and
physiological response. Alternatively, the kinetics of regeneration
and the time-period of appearance of Ngn3
+ cells in response to
the two types of injuries are distinct enough to preclude detection
of Ngn3
+ cells in our model. Additionally, post-transcriptional
regulation of Ngn3 within the regenerating pancreas may preclude
observation of Ngn3 positive cells as described elsewhere [58].
In summary, our findings suggest that the Cdk4-p16
Ink4a
pathway regulates the long-term quiescent state of b-cells within
islets and of potential progenitors within the pancreatic ductal
epithelium (Fig. 7). Thus, reduced Cdk4 activity, due to an intact
p16
Ink4a checkpoint, promotes an extended quiescent state, a
property exhibited by a majority of b-cells. Activation of Cdk4,
instead, overcomes the p16
Ink4a enforced quiescence and promotes
b-cell regeneration mechanisms
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Ink4a
checkpoint may preclude already cycling cells from exiting the cell
cycle into a quiescent state. Recruitment of quiescent cells to re-
enter the cell cycle and promotion of cells within the cell cycle to
continue dividing are central Cdk4-regulated mechanisms that
control reconstitution of b-cell mass.
Methods
Generation of Mice
All experiments used age-matched (6–8 weeks old) female and
male mice. All mice were housed in the animal facility at National
Institutes of Health (NIH) in accordance with NIH regulations
under specific pathogen-free conditions. All animal work is in
accordance with the protocols approved by the NIH Animal Use
and Care Committee.
Partial Pancreatectomy
The entire splenic portion of the pancreas was surgically
removed, resulting in a ,60% pancreatectomy. Sham operation
was performed as control for the multiple thymidine analog
labeling experiment. Blood glucose level was determined by using
an AscensiaELITE glucometer (Bayer Co., IN) before and after
pancreatectomy.
Figure 7. Proposed model of Cdk4-p16
Ink4a-regulated regeneration of b-cell mass via effects on the islets and the pancreatic ductal
epithelium. (A) Likeall cells, b-cellsandpancreaticductal epithelialcells alsotraverse the cellcycle.A significant fractionofthesecells are in the G0state
referredtoasquiescence.Our datasuggest thatCdk4promotescellcycle re-entryofquiescent cells. Inaddition, Cdk4enhances cellcycle progression via
stimulating G1 to S-phase transition. The p16
Ink4a-Cdk4 pathway shown is operational during recruitment of quiescent cells into the cell cycle and to
promote the G1 to S-phase cycling of cells already in cycle. Theseevents are suppressed by p16
Ink4a and promoted by Cdk4 which inactivates RB thereby
releasing E2F to drive S-phase progression. (B) Cdk4 appears to target the islets and the pancreatic ductal epithelium during a regenerative responset o
pancreatectomy and the proposed model outlines the events orchestrated by Cdk4. Islets are comprised of mature differentiated b-cells and a small
fraction of these b-cells undergo proliferation in response to regeneration. Cdk4 promotes limited replication of pre-existing b-cells. In addition, we
proposethatmajorityofb-cellsarequiescent.Inresponsetopancreatectomy,Cdk4recruitsthequiescentcellsintoanactivecellcycle,therebyincreasing
the pool of actively-dividing cells within the islet. Cdk4 appears to elicit a slightly different program in ducts in response to pancreatectomy. The duct is
mainly comprised of cytokeratin-positive (CK+) epithelial cells, with rare proliferating cells, a limited number of cells that express the early pancreatic
development marker, Pdx-1, and rare duct-associated ICCs. In response to pancreatectomy, the proliferation activity, Pdx-1 expression, and numbers of
ICCs are increased by the cell cycle progression in addition to recruitment of quiescent ductal cells into the active cell cycle.
doi:10.1371/journal.pone.0008653.g007
b-cell regeneration mechanisms
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Mice were given an intraperitoneal injection of 100 mg/Kg
B.W. BrdU (Sigma, St. Louis, MO) 16 hr before sacrifice.
Multiple Thymidine Analog Labeling
After partial pancreatectomy was performed, mice were
continuously administered 5-chloro-2-deoxyuridine (CldU) or 5-
iodo-2-deoxyuridine (IdU) in drinking water at 1 mg/ml for
different time periods according to labeling scheme. CldU and
BrdU were obtained from Sigma-Aldrich (St. Louis, Mo) and IdU
was purchased from MP Biomedicals (Santa Ana, CA). During the
chase period, the mice were given regular drinking water.
Immunohistochemistry
Pancreatic tissue samples were harvested and fixed in 10%
formalin solution. Paraffin-embedded sections (5 mm) were used in
immunohistochemistry analyses. Sections were immunostained
with guinea pig anti-insulin (Dako, Carpinteria, CA), mouse anti-
pan cytokeratin (Dako, Carpinteria, CA), mouse anti-BrdU (Dako,
Carpinteria, CA) or rabbit anti-Pdx-1 (Chemicon, Billerica, MA).
For multiple thymidine analog labeling study, the staining
procedure was according to the protocol published by Teta M.
et al. (29). In brief, sections were first rehydrated, then microwaved
in 0.01 M sodium citrate buffer, followed by permeabilization with
0.2% Triton X-100, incubation in 1.5 N HCL, and treatment with
0.25% trypsin (Invitrogen, Carlsbad, CA). Sections were then
incubated to detect CldU using a rat anti-BrdU antisera (BU1/75;
Accurate Chemical, Westbury, NY). IdU was detected using a
mouse anti-BrdU antisera (BD Biosciences, Franklin Lakes, NJ).
Guinea pig anti-insulin (Zymed Laboratories Inc., South San
Francisco, CA) was used followed by incubation with secondary
antisera conjugated to Cy2, Cy3 or Cy5 (Jackson ImmunoR-
esearch Laboratories, West Grove, PA).
Measurement of b-Cell Mass
For each pancreas, at least 3 inconsecutive sections with 150 mm
separation were randomly chosen for staining. Sections were
immunostained for insulin using a peroxidase indirect labeling
technique. Quantitative evaluation of total b-cell mass was
performed using image analysis software (Metamorph, CA). The
areas of insulin-positive cells, as well as that of total pancreatic
sections, were evaluated for each stained section. The relative
volume of b-cells was determined by the stereological morphom-
etry method, calculating the ratio between the area occupied by
immunoreactive cells and that occupied by the total pancreatic
tissue. Total b-cell mass per pancreas was derived by multiplying
this ratio by the total pancreatic weight. Results represent the
average from 4 animals per group.
Proliferation Analysis
Stained pancreatic sections showed either insulin-positive b-
cells or cytokeratin positive ductal cells together with BrdU-
positive staining. At least 1000 b-cell nuclei or CK-positive
ductal cells were counted per animal and at least 5 animals per
group were subject to such analyses. The proportion of BrdU-
positive b-cells (or BrdU-positive ductal cells) to total number of
b-cells (or total number of ductal cells) was quantified. The result
represents the percentage of proliferating rate in either b-cells or
ductal cells.
Islet-Like Cell Clusters (ICCs)
The number of islet-like cell clusters that comprise five or less b-
cells was counted subsequent to insulin immunohistochemistry.
Mathematical Modeling
We developed a mathematical model to examine the charac-
teristics of cell proliferation from the labeling results of CldU
+,
IdU
+, and CldU
+:IdU
+ cells (Fig. 3A). To distinguish the different
potential for cell proliferation, we separated cell populations into
quiescent and active cells. We denote the number of quiescent cells
with nQ and the number of active cells with nA. Quiescent cells do
not proliferate:
dnQ
dt
~0:
On the other hand, active cells proliferate with a given time-
dependent proliferation rate rt ðÞ . When active cells proliferate,
mother and daughter cells become labeled with thymidine analogs
in newly-synthesized DNA after mitosis. Note that we assumed
symmetric DNA segregation. Therefore, a proliferated active cell
becomes two labeled cells:
dnA
dt
~{rt ðÞ nA;
dnP
dt
~2rt ðÞ nA:
Here, we neglect multiple proliferations of once-proliferated
cells because the event is sufficiently rare (Table S1). The rate of
cell proliferation rt ðÞmay begin to increase by the PX stimulation,
and diminish after a certain time point. Therefore, we use the
following functional form multiplying two sigmoidal functions for
rising and falling phases:
rt ðÞ ~
rm
4
1ztanh
t{t1
t1
     
1{tanh
t{t2
t2
     
,
where rm is the magnitude of the proliferation rate; t1 and t2
represent the time points for rising and falling phases at which the
proliferation rate has the half maximal value of rm; finally, t1 and
t2 give the time scales for the slopes of the rising and falling phases,
respectively. The functional form is general enough to describe
even monotonically-increasing proliferation rate during a measur-
ing period, if t2 is larger than the given period. We apply this basic
model to examine cell proliferation. For a time period from an
initial time ti to a final time tf, the ratio of labeled cells to
unlabeled cells is
Lt i,tf
  
~
nP tf
  
{nP ti ðÞ
nQznA tf
  
znP tf
   :
For example, in the 2-2-4 labeling protocol, the CldU
+ labeling
ratio becomes L 0,2 ðÞ ; and the IdU
+ labeling ratio becomes
L 2,4 ðÞ . In case of single labeling with BrdU, the labeling ratio
from day 1 to day 2 becomes L 1,2 ðÞ . Note that we use
L0~r 0 ðÞ nA 0 ðÞ = nQ 0 ðÞ znA 0 ðÞ zr 0 ðÞ nA 0 ðÞ
  
for calculating basal
labeling ratio per day.
Optimization
We have two kinds of cell proliferation information. First, single
labeling with BrdU represents cell proliferation at day 0, 1, 2, and
14. Second, double labeling with CldU and IdU represents
accumulated cell proliferation for a given period that depends on
the experimental protocols: 2-2-4, 2-2-14, and 7-7-14 (Fig. 3B).
Therefore, we have totally ten sets of independent labeling data
b-cell regeneration mechanisms
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i=1, 2, …, 10 for each ensemble of j = 1 ,2 ,… ,l. Using the
mathematical model, we examine characteristics of cell prolifer-
ation which can appropriately explain the results of both
experiments. In the labeling results, scale of labeling ratio is not
comparable between BrdU and CldU/IdU labeling; BrdU could
detect more proliferated cells. The difference may result from the
injection method difference (intraperitoneal injection of BrdU vs.
by drinking water that includes CldU/IdU). It is also possible that
we observed CldU/IdU-labeled cells in lower laser intensity and
less laser-exposure time. Therefore, we introduce a scale
parameter g to scale up CldU/IdU labeling results; y’ ij~yij for
i=1, …, 4 and y’ ij~gyij for i=5, …, 10. To compare these y’ ij
with model predictions xi, we define a cost function, quantifying
the deviation between them,
E~
1
10l
X 10
i~1
X l
j~1
xi{y’ ij
dy’ i
Þ
2,
 
where we consider the experimental uncertainty dy’ i as a weight;
as the error dy’ i is smaller, we weight the corresponding data y’ ij as
more significant. The uncertainty is the standard deviation of data
y’ ij for the ith labeling ratio:
dy’ i~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
l
X l
j~1
y’ ij{  y y’ iÞ
2
 
v u u t
with the mean value   y y’ i~ 1
l
Pl
j~1 y’ ij.
Then, we simulate the model with the parallel tempering Monte-
Carlo (MC) method (60) for sampling in the seven-dimensional
parameter space, ~ p p~ rm,t1,t1,t2,t2,g,nQ
  
, and find the best
parameter~ p p0 minimizing the cost E. To obtain the global minimum
of the cost function, the MC method simultaneously runs several
chains with different temperatures (fluctuations). It allows both coarse
and fine search for the best parameter set. In particular, we used ten
temperatures from H1~0:1 to H10~1 with a uniform spacing
interval of 0.1. The updating probability of the MC simulation is
exp {HiE ~ p p ðÞ ½  for the ith chain. In addition, after every 20 time-
steps, we randomly picked two chains of different temperatures (Hi
and Hj) and exchanged their parameter set (~ p pi and ~ p pj)w i t ht h e
probability exp Hi{Hj
  
E ~ p pi ðÞ {E ~ p pj
   no hi
to find the global
minimum of the cost function more efficiently. After finding the best
parameter set, we ran 106 MC steps with one fixed temperature
(H~1) from the best parameter set found in the equilibration. From
the random walk of~ p p around~ p p0, we can estimate the average and the
standard deviation of optimal parameter values. At first, we found the
most probable values of the scale parameter g (2.460.9 and 2.360.8
for of b-cells in Cdk4
WT and Cdk4
R/R mice, respectively; 2.260.9
and 3.760.2 for of ductal cells in Cdk4
WT and Cdk4
R/R mice,
respectively). Therefore, as a universal scale parameter that should
consistentlyapplyalltheCldU/IdUlabelingexperiment,wefixedthe
scale parameter with g=3; then, we treated g as a constant, not a
parameter. For the model comparison, we used the Bayesian model
probability PM jD ðÞ that estimates how a model can describe a given
data well [59]. The probability can be calculated from the MC
simulation with different temperatures: for using 10 chanis,
{lnPM jD ðÞ ~1=10
P10
i~1   E Ei. Here,   E Ei means the average cost
for each temperature Hi. Note that for this calculation, there is no
exchange between MC chains of different temperatures in contrast to
the previous procedure for searching a global minimum of a cost
function. In addition, we used 105 MC steps to determine the model
probability PM jD ðÞ .
Statistical Analysis
All results are reported as means 6 SE. Statistical analysis was
performed by independent t-test (unpaired and two-tailed).
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